Using A 50-Color Spectral Cytometry Panel To Find Correlation Of ICANS In Clinical Trial Samples

Advancing immune profiling is critical for understanding therapeutic performance and patient outcomes. Explore a multi-modal approach that combines whole blood cell profiling, high-throughput spectral flow cytometry, and single-cell sequencing to uncover immune signatures linked to toxicity and treatment response. By integrating data from granulocyte phenotyping, PBMC characterization, and serum proteomics, researchers aim to identify predictive biomarkers and mechanistic insights into conditions like CRS and ICANS. The development of standardized, adaptable flow panels—built on OMIP frameworks and optimized for cell therapy trials—enables deeper analysis of rare cell subsets and CART cell functionality. Coupling these insights with robust computational clustering and correlation networks offers a powerful strategy for predicting outcomes and guiding intervention.

Learn how these innovations are shaping next-generation immunotherapy research.